We quantified the FRα binding sites of Skov-3 using an antibody-based flow cytometry approach and compared it to the expression profiles of the highly FRα-positive endometrial cancer cell line HeLa and the FRα low expressing lung cancer cell line A549 (Fig. 2a). This evidence concerns the gene FOLR1 and endometrial cancer.